Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.66B | 3.09B | 2.19B | 2.53B | 2.48B |
| Total Other Revenue | 17.08M | -- | 29.79M | -14.41M | 14.25M |
| Total Revenue | 2.68B | 3.09B | 2.21B | 2.52B | 2.50B |
| Cost of Revenue | 2.26B | 2.46B | 1.93B | 2.14B | 2.13B |
| Gross Profit | 420.30M | 633.76M | 280.60M | 373.38M | 373.45M |
| SG&A Expenses | 287.85M | 314.13M | 275.84M | 234.36M | 248.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.81M | 2.95M | 22.62M | -11.18M | 2.95M |
| Total Operating Expenses | 2.59B | 2.79B | 2.26B | 2.39B | 2.41B |
| Operating Income | 90.06M | 296.93M | -43.61M | 124.03M | 93.85M |
| Income Before Tax | 118.85M | 306.72M | -55.39M | 108.49M | 107.31M |
| Income Tax Expenses | 19.49M | 51.36M | -15.26M | 21.68M | 19.44M |
| Earnings from Continuing Operations | 99.36M | 255.37M | -40.14M | 86.80M | 87.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.27M | -4.97M | -4.83M | -1.68M | -6.19M |
| Net Income | 96.09M | 250.40M | -44.97M | 85.13M | 81.67M |
| EBIT | 90.06M | 296.93M | -43.61M | 124.03M | 93.85M |
| EBITDA | 111.46M | 317.36M | -22.96M | 145.38M | 116.50M |
| EPS Basic | 0.06 | 0.15 | -0.03 | 0.05 | 0.05 |
| Normalized Basic EPS | 0.03 | 0.12 | -0.02 | 0.05 | 0.04 |
| EPS Diluted | 0.06 | 0.15 | -0.03 | 0.05 | 0.05 |
| Normalized Diluted EPS | 0.03 | 0.12 | -0.02 | 0.05 | 0.04 |
| Average Basic Shares Outstanding | 1.62B | 1.63B | 1.63B | 1.63B | 1.63B |
| Average Diluted Shares Outstanding | 1.62B | 1.63B | 1.63B | 1.63B | 1.63B |
| Dividend Per Share | 0.06 | -- | 0.06 | 0.00 | 0.06 |
| Payout Ratio | 94.39% | 4.61% | -237.77% | 42.99% | 193.18% |